A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes.

Background: Off-label use of recombinant factor VIIa (rFVIIa) occurs despite minimal data. The purpose of this study was to describe prescribing practices and clinical outcomes for off-label rFVIIa use.

Study Design And Methods: A retrospective, multicenter chart audit of 315 nonhemophiliac patients was performed.